Gliminyle MV 1 Plus Tablet
Manufacturer
Erinyle Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Key Information
Short Description
Gliminyle MV 1 Plus Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Dosage Form
Tablet
Introduction
Gliminyle MV 1 Plus Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Gliminyle MV 1 Plus Tablet is to be taken empty stomach.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is unsafe to consume alcohol with Gliminyle MV 1 Plus Tablet.
Breastfeeding Warning
Gliminyle MV 1 Plus Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy Warning
Gliminyle MV 1 Plus Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Gliminyle MV 1 Plus Tablet is a combination of three antidiabetic medicines.
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Vogs GM 1mg/500mg/0.3mg Tablet
Tagg MV 1mg/500mg/0.3mg Tablet
Vokem GM 1mg/500mg/0.3mg Tablet
Elbose Trio Tablet
Metmost GV 1mg/500mg/0.3mg Tablet
Zinivog GM 1mg/500mg/0.3mg Tablet
Glimzab MV 1mg/500mg/0.3mg Tablet
Rozglyn MV 1mg/500mg/0.3mg Tablet
StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet
Volicure Trio 1mg/500mg/0.3mg Tablet
Frequently asked questions
What is Gliminyle MV 1 Plus Tablet?
Gliminyle MV 1 Plus Tablet is a combination medication that contains three active ingredients: Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, helping to regulate blood glucose levels when taken in conjunction with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose levels. This medication is not suitable for treating type 1 DM.
What are the possible side effects of Gliminyle MV 1 Plus Tablet?
Common side effects associated with Gliminyle MV 1 Plus Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any unusual symptoms or concerns, consult your healthcare provider.
Are there any specific conditions in which Gliminyle MV 1 Plus Tablet should not be taken?
Gliminyle MV 1 Plus Tablet should be avoided in patients with known allergies to any of its components or excipients. Additionally, it is contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Gliminyle MV 1 Plus Tablet?
No, it is not recommended to consume alcohol while taking Gliminyle MV 1 Plus Tablet. This combination may increase the risk of hypoglycemia and lactic acidosis. Consult your healthcare provider for personalized advice on medication use and alcohol consumption.
Can the use of Gliminyle MV 1 Plus Tablet cause hypoglycemia?
Yes, Gliminyle MV 1 Plus Tablet can cause hypoglycemia (low blood sugar). Symptoms may include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss or delay meals, drink alcohol, over-exercise, or take other antidiabetic medications. Regular blood sugar monitoring is essential. Always carry glucose tablets, honey, or fruit juice with you.
What are the instructions for the storage and disposal of Gliminyle MV 1 Plus Tablet?
Store Gliminyle MV 1 Plus Tablet in its original packaging, tightly closed. Follow the storage instructions provided on the packaging or label. Dispose of unused medication properly, ensuring it is not consumed by pets, children, or other individuals.
